Maryland Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,163
Closed -$845K 176
2017
Q4
$845K Sell
5,163
-75,963
-94% -$13.6M 0.13% 92
2017
Q3
$16.6M Sell
81,126
-9,359
-10% -$2.18M 2.56% 13
2017
Q2
$22M Sell
90,485
-280
-0.3% -$65.8K 3.16% 5
2017
Q1
$21.7M Sell
90,765
-7,235
-7% -$1.68M 3.25% 4
2016
Q4
$20.6M Sell
98,000
-9,939
-9% -$2.06M 3.18% 4
2016
Q3
$24.9M Sell
107,939
-3,417
-3% -$835K 3.73% 1
2016
Q2
$25.7M Sell
111,356
-8,928
-7% -$2.06M 4.05% 1
2016
Q1
$32.2M Buy
120,284
+8,421
+8% +$2.41M 4.64% 2
2015
Q4
$35M Buy
111,863
+10,835
+11% +$3.23M 5.15% 1
2015
Q3
$27.5M Sell
101,028
-1,501
-1% -$461K 4.64% 2
2015
Q2
$31.1M Buy
102,529
+650
+0.6% +$194K 4.84% 1
2015
Q1
$30.3M Sell
101,879
-217
-0.2% -$61.9K 4.73% 1
2014
Q4
$26.3M Sell
102,096
-1,450
-1% -$362K 4.32% 1
2014
Q3
$25M Sell
103,546
-1,180
-1% -$264K 4.32% 1
2014
Q2
$23.4M Sell
104,726
-1,584
-1% -$328K 4.1% 1
2014
Q1
$21.9M Sell
106,310
-25,490
-19% -$5.05M 4.02% 1
2013
Q4
$22.1M Sell
131,800
-12,515
-9% -$1.96M 3.51% 4
2013
Q3
$20.8M Sell
144,315
-2,835
-2% -$378K 3.37% 3
2013
Q2
$18.6M Buy
+147,150
New +$16.7M 3.23% 5

Other funds holding AGN

Maryland Capital Management's AGN Position: Q1 2018 in Review

Maryland Capital Management sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 5,163 shares — an estimated $845K sold.

Maryland Capital Management first reported a position in AGN in Q2 2013 and held it in 19 quarters. The position peaked at $35M in Q4 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Maryland Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Maryland Capital Management sold 5,163 Allergan plc shares in Q1 2018, an estimated $845K.
  • Maryland Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 19 quarters.
  • Maryland Capital Management's Allergan plc position peaked at $35M in Q4 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Maryland Capital Management's 13F filing for Q1 2018, filed 14 May 2018.